HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
about
High Mobility Group Box-1: A Missing Link between Diabetes and Its ComplicationsExpression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic RatsHMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.Thioredoxin-Interacting Protein (TXNIP) Suppresses Expression of Glutamine Synthetase by Inducing Oxidative Stress in Retinal Muller Glia Under Diabetic Conditions.
P2860
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
@en
type
label
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
@en
prefLabel
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
@en
P2093
P2860
P356
P1476
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy.
@en
P2093
Hailan Zhao
Jingzhuang Zhang
P2860
P304
P356
10.12659/MSM.894453
P577
2015-10-11T00:00:00Z